Xie Bo - Net Worth and Insider Trading
Xie Bo Net Worth
The estimated net worth of Xie Bo is at least $6 Million dollars as of 2025-04-08. Xie Bo is the senior management of KPC Pharmaceuticals Inc and owns about 384,489 shares of KPC Pharmaceuticals Inc (SHSE:600422) stock worth over $6 Million. Details can be seen in Xie Bo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Xie Bo has not made any transactions after 2021-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Xie Bo
Xie Bo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Xie Bo owns 1 companies in total, including KPC Pharmaceuticals Inc (SHSE:600422) .
Click here to see the complete history of Xie Bo’s form 4 insider trades.
Insider Ownership Summary of Xie Bo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600422 | KPC Pharmaceuticals Inc | 2021-06-07 | senior management |
Xie Bo Latest Holdings Summary
Xie Bo currently owns a total of 1 stock. Xie Bo owns 384,489 shares of KPC Pharmaceuticals Inc (SHSE:600422) as of June 7, 2021, with a value of $6 Million.
Latest Holdings of Xie Bo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600422 | KPC Pharmaceuticals Inc | 2021-06-07 | 384,489 | 16.48 | 6,336,379 |
Holding Weightings of Xie Bo
Xie Bo Form 4 Trading Tracker
According to the SEC Form 4 filings, Xie Bo has made a total of 1 transactions in KPC Pharmaceuticals Inc (SHSE:600422) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in KPC Pharmaceuticals Inc is the sale of 128,000 shares on June 7, 2021, which brought Xie Bo around $532,480.
Insider Trading History of Xie Bo
- 1
Xie Bo Trading Performance
GuruFocus tracks the stock performance after each of Xie Bo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Xie Bo is 2%. GuruFocus also compares Xie Bo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Xie Bo within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Xie Bo's insider trading performs compared to the benchmark.
Performance of Xie Bo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.1 | | | | | |
| Relative Return to S&P 500(%) | -1.59 | | | | | |
Xie Bo Ownership Network
Ownership Network List of Xie Bo
Ownership Network Relation of Xie Bo
Xie Bo Owned Company Details
What does KPC Pharmaceuticals Inc do?
Who are the key executives at KPC Pharmaceuticals Inc?
Xie Bo is the senior management of KPC Pharmaceuticals Inc. Other key executives at KPC Pharmaceuticals Inc include senior management Qu Xiao Ru , senior management Meng Li , and senior management Zhong Xiang Gang .
KPC Pharmaceuticals Inc (SHSE:600422) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of KPC Pharmaceuticals Inc (SHSE:600422) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
KPC Pharmaceuticals Inc (SHSE:600422)'s detailed insider trading history can be found in Insider Trading Tracker table.
KPC Pharmaceuticals Inc Insider Transactions
Xie Bo Mailing Address
Above is the net worth, insider trading, and ownership report for Xie Bo. Currently GuruFocus does not have mailing address information for Xie Bo.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
